PARENTERAL DRUGS (INDIA) LTD.

NSE : PDPLBSE : 524689ISIN CODE : INE904D01019Industry : Pharmaceuticals & DrugsHouse : Private

BSE4.050 (0 %)

PREV CLOSE ( ) 4.05

OPEN PRICE ( ) 4.14

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1915

TODAY'S LOW / HIGH ( )3.82 4.14

52 WK LOW / HIGH ( )3.18 5.4

NSE3.000 (0 %)

PREV CLOSE( ) 3.00

OPEN PRICE ( ) 3.00

BID PRICE (QTY) 3.00 (970)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 30

TODAY'S LOW / HIGH( ) 3.00 3.00

52 WK LOW / HIGH ( )2.8 4.8

More From Company Profile

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1983

Management Info

Manohar Lal Gupta - Chairman Vinod Kumar Gupta - Managing Director

Registered Office

Address 340, Laxmi Plaza,Laxmi Industrial Estate ,New Link Road, Andheri ( West ),
Mumbai,
Maharashtra-400053

Phone 022-61725900

Email pdpl@pdindia.com

Website www.pdindia.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

13Mar Corporate Insolvency Resolution Proce
This is to inform you that the 1st Meeting of Committee of Creditors of..

13Mar Corporate Insolvency Resolution Proce
This is to inform you that, the Committee of Creditors of Parenteral Dru..

13Mar Corporate Insolvency Resolution Proce
This is to inform you that, the list of Creditors of Parenteral Drugs (I..

23Feb Parenteral Drugs (India) informs about
Parenteral Drugs (India) has informed that Parenteral Drugs (India) (The..

23Feb Parenteral Drugs (India) informs about
Parenteral Drugs (India) has informed that the National Company Law Trib..

Financials

in Millions

	QTR Mar 22	ANNUAL 22
Net Profit	238.14	-763.61
Gross Profit	192.11	-1091.25
Operating Profit	-58.46	-149.41
Net Sales	18.13	85.68

EVENT CALENDAR

peer group

Alkem Laboratories (BSE) 3444.50 (1.12%)	M.Cap ( in Cr)41184.16
Caplin Point Lab (BSE) 808.85 (4.03%)	M.Cap ( in Cr)6141.90
AMI Organics (BSE) 1240.35 (2.58%)	M.Cap ( in Cr)4519.47
Alembic Pharma (BSE) 590.70 (5.41%)	M.Cap ( in Cr)11610.98
RPG Life Sciences (BSE) 824.00 (2.73%)	M.Cap ( in Cr)1362.81

	PROMOTERS	73.29%
	NON-INSTITUTION	26.71%
	MUTUAL FUNDS/UTI	0.01%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Scheme Name	Hold(%)
DSP Midcap Fund-Reg(G)	0.57

About Parenteral Drugs (India) Ltd.

Parenteral Drugs (India) Ltd. was incorporated in the year 1983. Its today's share price is 4.05. Its current market capitalisation stands at Rs 12.08 Cr. In the latest quarter, company has reported Gross Sales of Rs. 121.68 Cr and Total Income of Rs.122.31 Cr. The company's management includes Chhaya Gupta, Manish Verma, Dilip Kumar Sinha, Dharam Pal Khanna, Anil Mittal, Manohar Lal Gupta, Govind Das Garg, Vinod Kumar Gupta.

It is listed on the BSE with a BSE Code of 524689 , NSE with an NSE Symbol of PDPL and ISIN of INE904D01019. It's Registered office is at 340, Laxmi Plaza,Laxmi Industrial Estate ,New Link Road, Andheri ( West )Mumbai-400053, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Singhal Jain & Co, TN Unni & Co

About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang Contact Dp Support Contact Trading Support

Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading

Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays T+1 Settlement securities

Derivatives Updates Market Report Overview

IPO IPO Issues Performance News & Analysis

Commodities Market Movers News & Commentary MCX / NCDEX Holidays MCX Data feed product and Charges

Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Mutual Fund Terms & Conditions Mutual Privacy Policy

Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research

Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap Do's And Dont'sInvestor Complaint Data

Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances NPS Grievance Policy SEBI Scores RMS Policy Inspection CSR Committee CSR Policy

CSR Activities

FY-2020-2021 FY-2021-2022 FY-2022-2023

Investor Charter

Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs Investor Charter for Stock Broker Investor Charter for Research Investor Complaints -RA Investor Complaints-NBEPL

Evoting

NSDL Evoting CDSL Evoting

Client Bank Account list

Connect with Us

ATTENTION INVESTORS Depository IPO KYC

Inactive account treatment NBSPL Policy of AML NBEPL Policy of AML NBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar Updation Nirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019

Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment INZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300

For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain. |

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Type	Charges (POA Clients)	Charges (Non-POA Clients)
Margin Pledge Creation/Initiation	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)
Margin Pledge Release	INR 10.00 (Per Transaction)	INR 20.00 (Per Transaction)

Stock Price Quote